Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation.
Pérut V, Gauzit R, Kernéis S, Canouï E, Chedhomme FX, Batista R, Conort O, Bouam S, Raymond J, Loubinoux J, Chevallier A, Salmon-Ceron D.
Pérut V, et al.
Med Mal Infect. 2019 May;49(3):187-193. doi: 10.1016/j.medmal.2018.10.002. Epub 2018 Nov 9.
Med Mal Infect. 2019.
PMID: 30420165